Skip to main content
OpenTrials
Completed

NCT Number: NCT01296048

Clinical Test for Transtek Glass Body Analyzer

The clinical protocol of the clinical testing of this device:

1. Objective of the test: To verify the functions and efficiency of devices. 2. Test methods and procedures: Comparison Test. 3. DUT: Transtek Glass Body Analyzer, Model: GBF-830, GBF-835, GBF-950, and SA-15. 4. Comparison device: Scaleman Body Fat Scales, FS-148BW1 (Predicate Device). 5. Study endpoints: Transtek devices and the predicate device are substantial equivalence. 6. Statistical methodology used: Description of statistical methods. 7. Result: Efficiencies of Transtek devices and predicate device are in the same level.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Wuhou District Hospital

Chengdu, Sichuan, 610041, China

About this study

Hospital Information The data was collected by West China Medical College Clinical Investigator Team at Wuhou District Hospital, No. 9 Tongzilin Road, Wuhou District, Chengdu 610041, P. R. China.

Investigator: Catharine Zhang, Nurse A; Vivian Luo, Nurse B; Dr. James Zhu, Sponsor.

Contact Dr. James Zhu Tel: +86 1330 8036568 Used Equipments DUT (Device Under Test): Transtek Glass Body Analyzer, GBF-830, GBF-835, GBF-950, and SA-15.

Reference Device: Scaleman Body Fat Scales, FS-148BW1 (Predicate Device). Test Protocol

  • Test Purpose:

The aim of clinical test is to collect weight, body fat, total body water, bone mass, and muscle mass reading value which measured by DUT and reference device.

Note: GBF-835 has not total body water, bone mass, and muscle mass functions. So it just collects weight and body fat data.

  • Target Subject:

The subject database shall contain at least 25 male and 25 female subjects and all above 18 years old. Patient's population analysis is bellow.

  • Test procedures 1) Record the name, age, gender, and height of each subject. 2) Let subject seated calmly for two minutes before test, dry the feet. 3) Use device to measure weight, body fat, total body water, bone mass, and muscle mass; record reading value.
  • For each subject, repeat 3) to get 3 pairs measurements. 5) Repeat step 1) to 4) for every device (DUT: GBF-830, GBF-835, GBF-950, and SA-15; and reference device: FS-148BW1).
  • Repeat step 1) to 5) for each subject. 5. Note:
  • No motion and speaking are allowed during the measurement.
  • All DUT use the same algorithms, have the same number of electrodes and contact the patient at the same body locations (feet), and operate on the same frequency.
  • Test environment: Temperature: 20±1℃; Relative humidity: 40~50%.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • male,female

Exclusion criteria

  • below 18 years old

Treatment and study plan

Comparison test

Device

Scaleman Body Fat Scales, FS-148BW1, accuracy: ±0.1kg and range: 0-180kg.

Other names: Brand names: Scaleman, Serial numbers: SBFS1002-351, Code name: FS-148BW1

Primary outcomes

  1. Verify the accuracy of measure functions of device

    Time frame: 10 days

    Verify the functions and efficiency of these devices compare with a specified product.

Sponsors and collaborators

Lead sponsor

Leo Wang

Other

Collaborators

  • West China Hospital

Registry information

Official study title

Verify the Functions and Efficiency of Transtek Glass Body Analyzer, GBF-830, GBF-835, GBF-950, SA-15

Acronym: GBA

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
Feb 15, 2011
Registry last updated
Dec 23, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.